Rare diseases affect more than 350 million people worldwide but patients often face limited options for approved therapies. As a result, many patients have joined advocacy groups first and foremost to connect with others struggling with their rare disease, but also to promote research, unite multiple stakeholders and stimulate new possibilities …
![Covance Labs Rare and Orphan Drug Development DNA Strand](https://ddblog.labcorp.com/wp-content/uploads/2016/03/Covance-Labs-Rare-and-Orphan-Drug-Development-DNA-Strand.jpg)